Tags: Genomics, MultipleMyeloma
Tags: MultipleMyeloma, StemCellTransplant
Tags: MultipleMyeloma, TargetedTherapy
Dr. Paul Richardson led a study showing treatment with an investigational oral drug led to stable disease or better response in three fourths of patients with heavily pretreated multiple myeloma.
Tags: chemotherapy, MultipleMyeloma
Dr. Paul Richardson commented on the US Food and Drug Administration’s decision to expand the existing indication for lenalidomide (Revlimid) in combination with dexamethasone to include patients with newly diagnosed multiple myeloma.
Tags: BasicResearch, MultipleMyeloma
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: